Consumer Health

While overall consumer awareness of skin diseases and infections is increasing in Kenya, there remain areas where stigma persists, creating a reluctance among consumers to seek help. For instance, vaginal antifungals are linked to the stigma of…

Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…

The incidence of head lice is rising back to normal levels in 2023 as children circulate freely in schools and at social gatherings, and kids play close together. With retail volume sales back to pre-pandemic levels in 2022, demand for…

Dermatologicals is seeing solid current value growth in 2023, driven in part by higher retail prices. The category is benefiting from a return to normal daily lifestyles following the COVID-19 pandemic. Consumers’ skin is being more exposed to…

In Indonesia, according to data from the Indonesian Paediatrician Association (IDAI), around 7-35% of babies aged 6-12 months experience nappy (diaper) rash. With Indonesia’s population, that means between two million and 10 million babies suffer…

The above-average, high single-digit current value growth expected in topical germicidals/antiseptics in 2023 is also driving growth within overall dermatologicals in India, as this is the largest category. This surge in sales has been driven by…

All dermatologicals categories in Hungary are expected to post negative results in volume terms in 2023, in most cases for the second year in a row. Although a number of different factors have depressed demand in individual categories, the overall…

Dermatologicals in Hong Kong saw continued positive growth in 2023. Steady growth in antifungals was driven by medicated shampoos, vaginal antifungals and other dermatologicals such as topical allergy remedies/antihistamines, with hair loss…

Top topical antifungals brands such as Canesten (Bayer), Lamisil (Haleon), and Unesia (Genomma) keep this segment competitive as each continues vying for more market share. Consumer demand for these products is expected to remain strong over the…

Dermatologicals has seen demand weaken in the post-pandemic period. While certain COVID-19 related habits, such as the use of hand sanitisers, remain relevant and people in Greece continue to use them much more than they did in the past, this is a…

Dermatologicals again registered positive current value growth in 2023, continuing the trend of the previous years. The most dynamic category – hair loss treatments – continued to post strong growth. There are several reasons supporting the demand…

Dermatologicals is expected to register moderate constant value growth in 2023. Geopolitical tensions in the region have led to a significant increase in the number of immigrants from Ukraine, Russia and Belarus, and this is expected to contribute to…

Value growth for dermatologicals continues to slow in 2023 as local consumers prioritise the treatment of other health concerns. According to a study led by the French Society of Dermatology (SFD), one in three French citizen suffers from a skin…

Healthy growth in dermatologicals is stemming from launches of value-added products. There was a pause on most new product development activity during the COVID-19 crisis, but with the end of the pandemic, products that had been held back have been…

Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy…

Affordability is a key factor within dermatologicals, with some products on the landscape being very expensive for the average consumer. As such, people need to find products within their budget, allowing them to address their specific skin issues.…

Medicated shampoo is expected to register the highest current value growth in dermatologicals in 2023, with the big winner being Genommalab’s Medicasp. This brand has significantly increased value share over the review period. With substantial…

Despite the challenging economic conditions affecting the country, consumers continue to purchase a variety of dermatological products as awareness about treating certain conditions increases. Categories such as haemorrhoid treatments, medicated…